Starburst amacrine cells, involved in visual motion perception, loose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson's disease patients

• Published in: Translational neurodegeneration Vol. 12; no. 1; p. 17
• Main Authors: Sánchez-Sáez, Xavier, Ortuño-Lizarán, Isabel, Sánchez-Castillo, Carla, Lax, Pedro, Cuenca, Nicolás
• Format: Journal Article
• Language: English
• Published: England BioMed Central 03.04.2023
• Subjects: Amacrine Cells - metabolism; Antibodies; Datasets; Dopaminergic Neurons; Humans; Medical research; Motion Perception; Optic nerve; Parkinson Disease - metabolism; Parkinson's disease; Retina; Sheep; Software; Statistical analysis; United Kingdom > UK; Australia; Germany; ChAT amacrine cells; Human retina; Retinal neurodegeneration; Dopaminergic amacrine cells; Parkinson’s disease
• ISSN: 2047-9158; 2047-9158
• DOI: 10.1186/s40035-023-00348-y

The main clinical symptoms characteristic of Parkinson's disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion perception. Hence, we sought to determine if the starburst amacrine cells, which are the main cellular type involved in motion direction selectivity, are degenerated in PD and if the dopaminergic system is related to this degeneration. Human eyes from control (n = 10) and PD (n = 9) donors were available for this study. Using immunohistochemistry and confocal microscopy, we quantified starburst amacrine cell density (choline acetyltransferase [ChAT]-positive cells) and the relationship between these cells and dopaminergic amacrine cells (tyrosine hydroxylase-positive cells and vesicular monoamine transporter-2-positive presynapses) in cross-sections and wholemount retinas. First, we found two different ChAT amacrine populations in the human retina that presented different ChAT immunoreactivity intensity and different expression of calcium-binding proteins. Both populations are affected in PD and their density is reduced compared to controls. Also, we report, for the first time, synaptic contacts between dopaminergic amacrine cells and ChAT-positive cells in the human retina. We found that, in PD retinas, there is a reduction of the dopaminergic synaptic contacts into ChAT cells. Taken together, this work indicates degeneration of starburst amacrine cells in PD related to dopaminergic degeneration and that dopaminergic amacrine cells could modulate the function of starburst amacrine cells. Since motion perception circuitries are affected in PD, their assessment using visual tests could provide new insights into the diagnosis of PD.